Affibody is a clinical stage integrated biopharmaceutical company with a broad product pipeline focused on developing innovative bi- and multi-specific next generation biopharmaceutical drugs based on its unique proprietary technology platform, Affibody molecules.
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
| Ownership Private Company |
| Parent Company Patricia Industries |
Affibody is a clinical-stage integrated biopharmaceutical company that develops innovative bi- and multi-specific next-generation drugs based on its proprietary Affibody molecule technology platform.
Clinical-stage integrated biopharmaceutical company focused on developing drugs based on a proprietary technology platform.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with Affibody AB